1.Belcher, P, Lennox, SC. Avoidance of blood transfusion in coronary artery surgery: a trial of hydroxyethyl starch. Ann Thorac Surg. 1984;37:365–370.
2.McCarthy, PM, Popovsky, MA, Schaff, HV, et al. Effect of blood conservation efforts in cardiac operations at the Mayo Clinic. Mayo Clin Proc. 1988;63:225–229.
3.Munsch, CM, MacIntyre, E, Machin, SJ, Mackie, IJ, Treasure, T. Hydroxyethyl starch: an alternative to plasma for postoperative volume expansion after cardiac surgery. Br J Surg. 1988;75:675–678.
4.Hicks, GL, Jensen, LA, Norsen, LH, Quinn, JR, Stewart, SS, DeWeese, JA. Platelet inhibitors and hydroxyethyl starch: safe and cost-effective interventions in coronary artery surgery. Ann Thorac Surg. 1985;39:422–425.
5.Symington, BE. Hetastarch and bleeding complications. Ann Intern Med. 1986;105:627–628.
6.Cully, MD, Larson, CP, Silverberg, GD. Hetastarch coagulopathy in a neurosurgical patient. Anesthesiology 1987;66:706–707.
7.Lockwood, DN, Bullen, C, Machin, SJ. A severe coagulopathy following volume replacement with hydroxyethyl starch in a Jehovah's Witness. Anaesthesia. 1988;43:391–393.
8.Siegel, S. Nonparametric Statistics for Behavioral Sciences. New York, NY: John Wiley & Sons; 1981.
9.APHA. Standard Methods for the Examination of Water and Wastewater. New York, NY: APHA; 1960.
10.Booth, C. The limulus amoebocyte lysate (LAL) assay-a replacement for the rabbit pyrogen test. Dev Biol Stand. 1986;64:271–273.
11.Harker, LA. Bleeding after cardiopulmonary bypass. N Engl J Med. 1986;314:1446–1447.
12.Salzman, EW, Weinstein, MJ, Weintraub, RM, et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. N Engl J Med. 1986;314: 1402–1406.
13.Strauss, RG, Stump, DC, Henriksen, A, Saunders, R. Effects of hydroxyethyl starch on fibrinogen. fibrin clot formation, and fibrinolysis. Transfusion. 1984;25:230–234.
14.Macintyre, E, Mackie, IJ, Ho, D, Tinker, J, Bullen, C, Machin, SJ. The haemostatic effects of hydroxyethyl starch (HES) used as a volume expander. Intensive Care Med. 1985;11:300–303.
15.Kirklin, JK, Lell, WA, Kouchoukos, NT. Hydroxyethyl starch versus albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularization. Ann Thorac Surg. 1984;37:40–46.
16.Stump, DC, Strauss, RG, Henriksen, RA, Petersen, RE, Saunders, R. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion. 1985;25:349–354.
17.Bick, RL. Hemostasis defects associated with cardiac surgery, prosthetic devices, and other extracorporeal circuits. Semin Thromb Hemost. 1985;11:249–280.
18.Strauss, RG. Review of the effects of hydroxyethyl starch on the blood coagulation system. Transfusion. 1981;21:299–302.
19.Gonzalez-Santos, JM, Ennabli, K, Pelletier, LC. Coronary artery bypass surgery in the eighth decade of life: experience with 101 patients. Thorac Cardiovasc Surg. 1984;32:341–345.
20.Mullany, CJ, Clarebrough, JK, White, AL, Wilson, AC. Open heart surgery in the elderly. Aust NZ J Surg. 1987;57:733–737.
21.Silvay, G, Bodner, N, Koffsky, B, Mindich, BP, Litwak, RS, Kaplan, JA. Open heart surgery in patients in the eighth and ninth decades of life. J Am Geriatr Soc. 1988;36:1123–1124.
22.Hughes, CF, Grant, AF, Leckie, BD, Baird, DK. Cardioplegic solution: a contamination crisis. J Thorac Cardiovasc Surg. 1986;91:296–302.
23.Andersen, LW, Baek, L, Degn, H, Lehd, J, Krasnik, M, Rasmussen, JP. Presence of circulating endotoxins during cardiac operations. J Thorac Cardiovasc Surg. 1987;93:115–119.
24.Bland, LE, Villarino, ME, Arduino, MJ, et al. Bacteriologic and endotoxin analysis of salvaged blood used in autologous transfusions during open heart surgery procedures. J Thorac Cardiovasc Surg. [in press].
25.National Center for Health Statistics. National Hospital Discharge Survey. Hyattsville, MD: US Department of Health and Human Services; 1987.